completely agree with what TheAnalyst said, 2RT is certainly exciting but iTrack advance is the main play atm. Whilst 2RT is some time away there should be some pretty major announcements (partnership, clinical trial info etc) this year which could result in 2RT having an actual positive impact on the share price, but for now we should be focused on iTrack advance as the certainty around that and the incredible potential of it in a super fast growing market is the main reason for this stock being so undervalued
Nova Eye Medical (EYE) Discussion, page-39
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $62.91M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 26.5¢ | $40.17K | 150.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 43000 | 1 |
View Market Depth
| Last trade - 15.35pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
27.0¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 26.5¢ | 27.0¢ | 26.5¢ | 19422 | ||
| Last updated 15.04pm 26/04/2024 ? | |||||
| EYE (ASX) Chart |